Radiesse - (FDA approved 12/2006) www.radiesse.com

    The main component of Radiesse is Calcium Hydroxylapatite which is a biocompatible (compatible with living systems), biodegradable (dissolves in the body) material. Calcium hydroxylapatite is identical in composition to the mineral portion of teeth and bone. Due to this there is no need for pretreatment skin testing. Hydroxylapatite has a history of safe use in otology (ears), laryngeal (vocal chords), dental and orthopedic applications. It is the only filler that immediately replenishes lost volume and stimulates the production of your own natural collagen for long-lasting results. However it is now believed that several products may have this action. It is clinically proven to last a year or more in many patients.


    Radiesse will be largely unavailable for cosmetic purposes until approximately the 2nd quarter of 2013 in the US. Merz Pharmaceuticals and Merz Aesthetics (Merz) are under an injunction prohibiting them from “providing or selling...or soliciting purchases of Radiesse and Xeomin (their competitor to Botox and Dysport) for cosmetic purposes. The injunction has nothing to do with safety or efficacy issues but rather to unfair business practices with their competitors.